Sun, Jiangwei
Fang, Fang
Olén, Ola
Song, Mingyang
Halfvarson, Jonas
Roelstraete, Bjorn
Khalili, Hamed
Ludvigsson, Jonas F.
Funding for this research was provided by:
Chinese Scholarship Council
Karolinska Institutet
Swedish Research Council
the FORTE foundation
the Swedish Cancer Foundation
Karolinska Institute
Article History
Received: 14 June 2022
Accepted: 10 August 2022
First Online: 13 August 2022
Declarations
:
: This study was approved by the Stockholm Ethics Review Board (2014/1287–31/4). Due to its register-based nature, individual informed consent was waived by the board.
: Not applicable. No individual person’s data are presented in the manuscript.
: JFL coordinates a study on behalf of the Swedish IBD quality register (SWIBREG) and that study has received funding from Janssen corporation.OO has been PI on projects at Karolinska Institutet, financed by grants from Janssen, Takeda, AbbVie, and Ferring, and Karolinska Institutet has received fees for lectures and participation on advisory boards from Janssen, Ferring, Takeda, Bristol Myer Squibb, Galapagos, and Pfizer. OO also reports a grant from Pfizer in the context of a national safety monitoring program.JH served as speaker and/or advisory board member for AbbVie, Celgene, Celltrion, Dr Falk Pharma and the Falk Foundation, Ferring, Galapagos, Gilead, Hospira, Index Pharma, Janssen, MEDA, Medivir, MSD, Novartis, Pfizer, Prometheus Laboratories Inc., Sandoz, Shire, Takeda, Thermo Fisher Scientific, Tillotts Pharma, Vifor Pharma, UCB and received grant support from Janssen, MSD and Takeda.HK is supported by the American College of Gastroenterology Senior Research Award and the Beker Foundation; HK has received consulting fees from Abbvie and Takeda; HK has also received grant funding from Pfizer and Takeda.The other authors declare that they have no competing interests.